Melanoma

About
Mappings

OncoTree: Melanoma (oncotree:MEL)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) BRAF p.V600E Melanoma Atezolizumab, Cobimetinib, Vemurafenib FDA
Sensitivity (+) BRAF p.V600K Melanoma Atezolizumab, Cobimetinib, Vemurafenib FDA
Sensitivity (+) BRAF p.V600E Melanoma Binimetinib, Encorafenib FDA
Sensitivity (+) BRAF p.V600K Melanoma Binimetinib, Encorafenib FDA
Sensitivity (+) BRAF p.V600E Melanoma Cobimetinib, Vemurafenib FDA
Sensitivity (+) BRAF p.V600K Melanoma Cobimetinib, Vemurafenib FDA
Sensitivity (+) BRAF p.V600E Melanoma Dabrafenib FDA
Sensitivity (+) BRAF p.V600E Melanoma Dabrafenib, Trametinib FDA
Sensitivity (+) BRAF p.V600K Melanoma Dabrafenib, Trametinib FDA
Sensitivity (+) BRAF p.V600E Melanoma Dabrafenib, Trametinib FDA
Sensitivity (+) BRAF p.V600K Melanoma Dabrafenib, Trametinib FDA
Sensitivity (+) BRAF p.V600E Melanoma Binimetinib, Encorafenib FDA
Sensitivity (+) BRAF p.V600K Melanoma Binimetinib, Encorafenib FDA
Sensitivity (+) BRAF p.V600E Melanoma Trametinib FDA
Sensitivity (+) BRAF p.V600K Melanoma Trametinib FDA
Sensitivity (+) BRAF p.V600E Melanoma Dabrafenib, Trametinib FDA
Sensitivity (+) BRAF p.V600K Melanoma Dabrafenib, Trametinib FDA
Sensitivity (+) BRAF p.V600E Melanoma Dabrafenib, Trametinib FDA
Sensitivity (+) BRAF p.V600K Melanoma Dabrafenib, Trametinib FDA
Sensitivity (+) BRAF p.V600E Melanoma Vemurafenib FDA
Sensitivity (+) BRAF p.V600E Melanoma Binimetinib, Encorafenib HC
Sensitivity (+) BRAF p.V600E Melanoma Cobimetinib, Vemurafenib HC
Sensitivity (+) BRAF p.V600K Melanoma Cobimetinib, Vemurafenib HC
Sensitivity (+) BRAF p.V600E Melanoma Pembrolizumab HC
Sensitivity (+) BRAF p.V600K Melanoma Pembrolizumab HC
Sensitivity (+) BRAF p.V600E Melanoma Trametinib HC
Sensitivity (+) BRAF p.V600K Melanoma Trametinib HC
Sensitivity (+) BRAF p.V600E Melanoma Binimetinib, Encorafenib HC
Sensitivity (+) BRAF p.V600K Melanoma Binimetinib, Encorafenib HC
Sensitivity (+) BRAF p.V600E Melanoma Nivolumab HC
Sensitivity (+) BRAF p.V600K Melanoma Nivolumab HC
Sensitivity (+) BRAF p.V600E Melanoma Dabrafenib HC
Sensitivity (+) BRAF p.V600K Melanoma Dabrafenib HC
Sensitivity (+) BRAF p.V600E Melanoma Vemurafenib HC
Sensitivity (+) BRAF p.V600K Melanoma Vemurafenib HC